Greenway offers customers CommonWell Alliance functionality

The sixth most popular EHR vendor announced the ability of its customers to use CommonWell Health Alliance services to exchange clinical information from its system with other alliance participants at no cost.

Greenway Health's Greenway Prime Suite customers can access CommonWell functionality directly from the EHR. CommonWell, established in 2012, is a not-for-profit trade association of health IT companies working together to create universal access to healthcare data. 

“At Greenway Health, we don’t believe in barriers to clinical data,” said Greenway Health CEO Tee Green, in a release. “Innovative partnerships like CommonWell are one way we enable the secure data flow that leads to connected care and, ultimately, better health outcomes. The alliance gives our customers and other participants a more secure way to gain a more comprehensive view of the patient’s health history, regardless of the point of care or what information system was used. This will enable clinicians to make the most informed decisions possible.”

Greenway Health is one of the seven founding members of CommonWell.

Plans currently call for CommonWell services to be available to users of Greenway Health’s other main EHR/practice management platforms, Intergy and SuccessEHS, at a later date.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.